• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Preventive effect of tertiary lymphoid structures on lymph node metastasis of lung adenocarcinoma.三级淋巴结构对肺腺癌淋巴结转移的预防作用。
Cancer Immunol Immunother. 2023 Jun;72(6):1823-1834. doi: 10.1007/s00262-022-03353-8. Epub 2023 Jan 23.
2
The Presence of Tertiary Lymphoid Structures Provides New Insight Into the Clinicopathological Features and Prognosis of Patients With Breast Cancer.三阴性淋巴结构的存在为乳腺癌患者的临床病理特征和预后提供了新的见解。
Front Immunol. 2022 May 19;13:868155. doi: 10.3389/fimmu.2022.868155. eCollection 2022.
3
Low-dose radiotherapy promotes the formation of tertiary lymphoid structures in lung adenocarcinoma.低剂量放射治疗促进肺腺癌中三级淋巴样结构的形成。
Front Immunol. 2024 Jan 8;14:1334408. doi: 10.3389/fimmu.2023.1334408. eCollection 2023.
4
Integrated analysis of tertiary lymphoid structures and immune infiltration in ccRCC microenvironment revealed their clinical significances: a multicenter cohort study.三阴性乳腺癌微环境中三级淋巴结构和免疫浸润的综合分析揭示了它们的临床意义:一项多中心队列研究。
J Immunother Cancer. 2024 Jun 21;12(6):e008613. doi: 10.1136/jitc-2023-008613.
5
Tertiary lymphoid structures correlate with enhancement of antitumor immunity in esophageal squamous cell carcinoma.三级淋巴结构与食管鳞癌抗肿瘤免疫增强相关。
Br J Cancer. 2023 Oct;129(8):1314-1326. doi: 10.1038/s41416-023-02396-7. Epub 2023 Aug 21.
6
Peritumoral tertiary lymphoid structure and tumor stroma percentage predict the prognosis of patients with non-metastatic colorectal cancer.肿瘤周围三级淋巴结构和肿瘤间质百分比可预测非转移性结直肠癌患者的预后。
Front Immunol. 2022 Sep 16;13:962056. doi: 10.3389/fimmu.2022.962056. eCollection 2022.
7
Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer.结直肠癌肺转移灶中的肿瘤浸润淋巴细胞亚群和三级淋巴结构
Clin Exp Metastasis. 2016 Oct;33(7):727-39. doi: 10.1007/s10585-016-9813-y. Epub 2016 Jul 23.
8
The prognostic value and molecular properties of tertiary lymphoid structures in oesophageal squamous cell carcinoma.食管鳞状细胞癌中三级淋巴结构的预后价值和分子特性。
Clin Transl Med. 2022 Oct;12(10):e1074. doi: 10.1002/ctm2.1074.
9
Clinical relevance of tertiary lymphoid structures in esophageal squamous cell carcinoma.食管鳞癌中三级淋巴结构的临床意义。
BMC Cancer. 2022 Jun 24;22(1):699. doi: 10.1186/s12885-022-09777-w.
10
Integrated analysis of tertiary lymphoid structures in relation to tumor-infiltrating lymphocytes and patient survival in pancreatic ductal adenocarcinoma.胰腺导管腺癌中三级淋巴结构与肿瘤浸润淋巴细胞及患者生存的综合分析。
J Gastroenterol. 2023 Mar;58(3):277-291. doi: 10.1007/s00535-022-01939-8. Epub 2023 Jan 27.

引用本文的文献

1
An MRI-based model for preoperative prediction of tertiary lymphoid structures in patients with gallbladder cancer.一种基于磁共振成像的胆囊癌患者三级淋巴结构术前预测模型。
Insights Imaging. 2025 Aug 30;16(1):189. doi: 10.1186/s13244-025-02007-4.
2
In-depth insight into tumor-infiltrating stromal cells linked to tertiary lymphoid structures and their prospective function in cancer immunotherapy.深入了解与三级淋巴结构相关的肿瘤浸润性基质细胞及其在癌症免疫治疗中的潜在功能。
Exp Hematol Oncol. 2025 Aug 10;14(1):105. doi: 10.1186/s40164-025-00695-8.
3
Recent advances in biomarkers for predicting the efficacy of immunotherapy in non-small cell lung cancer.预测非小细胞肺癌免疫治疗疗效的生物标志物的最新进展。
Front Immunol. 2025 May 8;16:1554871. doi: 10.3389/fimmu.2025.1554871. eCollection 2025.
4
The role of B cell immunity in lung adenocarcinoma.B细胞免疫在肺腺癌中的作用。
Genes Immun. 2025 May 13. doi: 10.1038/s41435-025-00331-9.
5
Tertiary lymphoid structures in gliomas: impact on tumour immunity and progression.胶质瘤中的三级淋巴结构:对肿瘤免疫和进展的影响
J Transl Med. 2025 May 9;23(1):528. doi: 10.1186/s12967-025-06510-6.
6
The correlation of tertiary lymphoid structures with tumor spread through air spaces and prognosis in lung adenocarcinoma: focusing on pathological spatial features.三级淋巴结构与肺腺癌气腔播散及预后的相关性:聚焦于病理空间特征
World J Surg Oncol. 2025 Mar 19;23(1):94. doi: 10.1186/s12957-025-03751-z.
7
Role of tertiary lymphoid structures and B cells in clinical immunotherapy of gastric cancer.三级淋巴结构和B细胞在胃癌临床免疫治疗中的作用。
Front Immunol. 2025 Jan 7;15:1519034. doi: 10.3389/fimmu.2024.1519034. eCollection 2024.
8
The predictive role of tertiary lymphoid structures in the prognosis and response to immunotherapy of lung cancer patients: a systematic review and meta-analysis.三级淋巴结构在肺癌患者预后及免疫治疗反应中的预测作用:一项系统评价和荟萃分析
BMC Cancer. 2025 Jan 15;25(1):87. doi: 10.1186/s12885-025-13484-7.
9
Inflammation, tertiary lymphoid structures, and lung cancer: a bibliometric analysis.炎症、三级淋巴结构与肺癌:一项文献计量分析
Transl Lung Cancer Res. 2024 Oct 31;13(10):2636-2648. doi: 10.21037/tlcr-24-350. Epub 2024 Oct 28.
10
Maturity and density of tertiary lymphoid structures associate with tumor metastasis and chemotherapy response.三级淋巴结构的成熟度和密度与肿瘤转移及化疗反应相关。
Front Med (Lausanne). 2024 Oct 18;11:1435620. doi: 10.3389/fmed.2024.1435620. eCollection 2024.

本文引用的文献

1
The PD-1/PD-L1-Checkpoint Restrains T cell Immunity in Tumor-Draining Lymph Nodes.PD-1/PD-L1 检查点抑制肿瘤引流淋巴结中的 T 细胞免疫。
Cancer Cell. 2020 Nov 9;38(5):685-700.e8. doi: 10.1016/j.ccell.2020.09.001. Epub 2020 Oct 1.
2
New predictors for immunotherapy responses sharpen our view of the tumour microenvironment.新的免疫治疗反应预测因子使我们更深入地了解肿瘤微环境。
Nature. 2020 Jan;577(7791):474-476. doi: 10.1038/d41586-019-03943-0.
3
B cells are associated with survival and immunotherapy response in sarcoma.B 细胞与肉瘤的生存和免疫治疗反应有关。
Nature. 2020 Jan;577(7791):556-560. doi: 10.1038/s41586-019-1906-8. Epub 2020 Jan 15.
4
B cells and tertiary lymphoid structures promote immunotherapy response.B 细胞和三级淋巴结构促进免疫治疗反应。
Nature. 2020 Jan;577(7791):549-555. doi: 10.1038/s41586-019-1922-8. Epub 2020 Jan 15.
5
Tertiary lymphoid structures improve immunotherapy and survival in melanoma.三级淋巴结构可改善黑色素瘤的免疫治疗和生存率。
Nature. 2020 Jan;577(7791):561-565. doi: 10.1038/s41586-019-1914-8. Epub 2020 Jan 15.
6
Tertiary Lymphoid Organs in Cancer Immunology: Mechanisms and the New Strategy for Immunotherapy.癌症免疫学中的三级淋巴器官:机制与免疫治疗新策略。
Front Immunol. 2019 Jun 20;10:1398. doi: 10.3389/fimmu.2019.01398. eCollection 2019.
7
Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology.免疫纤维母细胞是三级淋巴结构形成和局部病理的关键驱动因素。
Proc Natl Acad Sci U S A. 2019 Jul 2;116(27):13490-13497. doi: 10.1073/pnas.1905301116. Epub 2019 Jun 18.
8
Tertiary lymphoid structures in the era of cancer immunotherapy.癌症免疫治疗时代的三级淋巴结构。
Nat Rev Cancer. 2019 Jun;19(6):307-325. doi: 10.1038/s41568-019-0144-6.
9
Tertiary Lymphoid Structures in Colorectal Cancers and Their Prognostic Value.结直肠癌中的三级淋巴结构及其预后价值。
Open Access Maced J Med Sci. 2018 Oct 9;6(10):1824-1828. doi: 10.3889/oamjms.2018.341. eCollection 2018 Oct 25.
10
Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC).新辅助抗 PD-1 治疗后切除的非小细胞肺癌的反应的病理特征:提出了定量免疫相关病理反应标准(irPRC)。
Ann Oncol. 2018 Aug 1;29(8):1853-1860. doi: 10.1093/annonc/mdy218.

三级淋巴结构对肺腺癌淋巴结转移的预防作用。

Preventive effect of tertiary lymphoid structures on lymph node metastasis of lung adenocarcinoma.

作者信息

Wakasu Sho, Tagawa Tetsuzo, Haratake Naoki, Kinoshita Fumihiko, Oku Yuka, Ono Yuki, Takenaka Tomoyoshi, Oda Yoshinao, Shimokawa Mototsugu, Mori Masaki

机构信息

Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-Ku, Fukuoka, 812-8582, Japan.

Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

出版信息

Cancer Immunol Immunother. 2023 Jun;72(6):1823-1834. doi: 10.1007/s00262-022-03353-8. Epub 2023 Jan 23.

DOI:10.1007/s00262-022-03353-8
PMID:36688996
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10992259/
Abstract

BACKGROUND

Ectopic lymphoid formations are called tertiary lymphoid structures (TLSs). TLSs in cancer have been reported to be associated with good prognosis and immunotherapy response. However, the relationship between TLSs and lymph node (LN) metastasis is unclear.

METHODS

We analyzed 218 patients with radically resected lung adenocarcinoma. TLSs were defined as the overlap of T cell zone and B cell zone. Granzyme B cells were defined as cytotoxic lymphocytes. We evaluated phenotypes of lymphocytes in TLSs, tumor-infiltrating lymphocytes (TILs) and LNs by immunohistochemistry. We divided the patients into mature TLS (DC-Lamp high) and immature TLS (DC-Lamp low) groups. The relationship between TLS maturation and clinicopathological factors was analyzed.

RESULTS

The mature TLS group was associated with significantly lower frequency of LN metastasis (P < 0.0001) and early cancer stage (P = 0.0049). The mature TLS group had significantly more CD8 (P = 0.0203) and Foxp3 (P = 0.0141) cells in TILs than the immature TLS group had. Mature TLSs were independently associated with a favorable overall survival (hazard ratio [HR] = 0.17, P = 0.0220) and disease-free survival (HR = 0.54, P = 0.0436). Multivariate analysis showed that mature TLS was an independent low-risk factor for LN metastasis (odds ratio = 0.06, P = 0.0003). The number of cytotoxic lymphocytes in LNs was higher in the mature TLS group than in the immature group (20.0 vs. 15.1, P = 0.017).

CONCLUSION

Mature TLSs were associated with an increased number of cytotoxic lymphocytes in draining LNs, a lower frequency of LN metastasis, and favorable outcomes. Mature TLSs may support antitumor immunity by lymphocyte activation.

摘要

背景

异位淋巴组织形成被称为三级淋巴结构(TLSs)。据报道,癌症中的TLSs与良好的预后和免疫治疗反应相关。然而,TLSs与淋巴结(LN)转移之间的关系尚不清楚。

方法

我们分析了218例接受根治性切除的肺腺癌患者。TLSs被定义为T细胞区和B细胞区的重叠区域。颗粒酶B细胞被定义为细胞毒性淋巴细胞。我们通过免疫组织化学评估了TLSs、肿瘤浸润淋巴细胞(TILs)和LN中淋巴细胞的表型。我们将患者分为成熟TLS(DC-Lamp高)组和不成熟TLS(DC-Lamp低)组。分析了TLS成熟与临床病理因素之间的关系。

结果

成熟TLS组的LN转移频率显著较低(P < 0.0001),且癌症分期较早(P = 0.0049)。成熟TLS组的TILs中CD8(P = 0.0203)和Foxp3(P = 0.0141)细胞显著多于不成熟TLS组。成熟TLSs与良好的总生存期(风险比[HR] = 0.17,P = 0.0220)和无病生存期(HR = 0.54,P = 0.0436)独立相关。多变量分析显示,成熟TLS是LN转移的独立低风险因素(比值比 = 0.06,P = 0.0003)。成熟TLS组LN中的细胞毒性淋巴细胞数量高于不成熟组(20.0对15.1,P = 0.017)。

结论

成熟TLSs与引流LN中细胞毒性淋巴细胞数量增加、LN转移频率降低和良好预后相关。成熟TLSs可能通过淋巴细胞激活来支持抗肿瘤免疫。